Patient Guide: A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 20 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05864846
Status: ACTIVE_NOT_RECRUITING
Condition: Tuberous Sclerosis, Sclerosis
Phase: PHASE4

Where You Can Participate

This study is available at 20 locations across the country.

Top locations include:
  • • Aurora, Colorado
  • • New Haven, Connecticut
  • • Gainesville, Florida
  • • And 17 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex - Join Clinical Trial NCTNCT05864846

How to Join This Clinical Trial - NCTNCT05864846

Learn how to participate in this PHASE4 trial studying an investigational therapy for Tuberous Sclerosis, Sclerosis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Tuberous Sclerosis, Sclerosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Tuberous Sclerosis, Sclerosis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05864846 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 20 locations. Find a study site near you:

Clinical Research Site

Aurora, Colorado 80045 - United States

Status: Contact for availability

Clinical Research Site

New Haven, Connecticut 06519 - United States

Status: Contact for availability

Clinical Research Site

Gainesville, Florida 32608 - United States

Status: Contact for availability

Clinical Research Site

Miami, Florida 33155 - United States

Status: Contact for availability

Clinical Research Site

Boston, Massachusetts 02114 - United States

Status: Contact for availability

Clinical Research Site

Roseville, Minnesota 55113 - United States

Status: Contact for availability

Clinical Research Site

Winston-Salem, North Carolina 27157 - United States

Status: Contact for availability

Clinical Research Site

Cincinnati, Ohio 45229 - United States

Status: Contact for availability

Clinical Research Site

Philadelphia, Pennsylvania 19104 - United States

Status: Contact for availability

Clinical Research Site

Memphis, Tennessee 38103 - United States

Status: Contact for availability

And 10 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Tuberous Sclerosis, Sclerosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships